Dermatology
Latest News
EMA panel backs baricitinib for moderate to severe atopic dermatitis
If approved in Europe, it will be the first Janus kinase inhibitor and first oral medication indicated to treat patients with AD.
From the Journals
Biologics for psoriasis may also reduce coronary plaque
Cardiac CT scans reveal a reduction in lipid-rich necrotic core (LRNC) in patients who were receiving biologics.
From the Journals
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments...
Feature
Psoriasis, PsA, and pregnancy: Tailoring treatment with increasing data
Two experts give their up-to-date views on managing psoriasis and psoriatic arthritis before, during, and after pregnancy.
Feature
The long road to a PsA prevention trial
Researchers zero in on biologics, diet, and risk modeling to craft studies on a challenging population.
Latest News
FDA approves topical antiandrogen for acne
Approval was based in part on a pair of phase 3, double-blind, vehicle-controlled, 12-week, randomized trials.
Conference Coverage
Mapping melasma management
Continuous therapy is warranted to prevent recurrences.
From the Journals
Large study finds no link between TCI use, skin cancer in patients with AD
“Controversy has surrounded the association between TCI exposure and KC risk since the black-box warning was issued by the FDA.”
From the Journals
TNF inhibitors linked to inflammatory CNS events
The authors do not caution “against using these therapies in appropriate patients,” and it is unclear whether this association “represents de novo...
News
FDA updates hydrochlorothiazide label to include nonmelanoma skin cancer risk
Patients should continue taking the antihypertensive drug unless their doctor says otherwise, according to an FDA...
From the Journals
Compression therapy cuts cellulitis risk in chronic leg edema
This is the first study to show that "compression therapy dramatically reduces the risk of cellulitis for patients with chronic edema."